Abstract
Abstract
Objective
To characterize the representation of Black and Hispanic cancer patients in tobacco treatment trials, and to offer recommendations for future research.
Methods
We conducted two systematic searches of the literature (2018, 2021) using 5 databases (MEDLINE via EBSCO, Pubmed, PsycInfo, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Excerpta Medica Database (EMBASE)) to examine the prevalence of tobacco trials that included Black or Hispanic cancer patients. Two coders independently screened all articles at title, abstract, and full-text to identify eligible trials. Information about the proportion of Black and Hispanic patients included, trial design features, and whether the authors analyzed outcomes for Black and Hispanic patients were documented.
Results
Of 4682 identified studies, only 10 published trials included and reported on the rates of Black or Hispanic cancer patients enrolled in their tobacco trial. The proportion of enrolled Black cancer patients ranged from 2 to 55.6%. Only our studies documented enrollment rates for Hispanics, and rates were less than 6%. None of the studies offered strategies to promote or the accrual of Black or Hispanic patients.
Discussion
There remains a large gap in the literature regarding the reach and efficacy of tobacco treatment for Black and Hispanic cancer patients. Black and Hispanic cancer patients remain largely under-represented in tobacco cessation trials, limiting the applicability of existing, evidence-based treatments. To optimize intervention generalizability, future studies should emphasize the targeted recruitment and engagement of these patients in tobacco trials.
Funder
National Cancer Institute
National Institute of Cancer
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health,Health Policy,Sociology and Political Science,Anthropology,Health (social science)
Reference40 articles.
1. National Cancer Institute. Cancer health disparities. 2018. https://www.cancer.gov/about-nci/organization/crchd/cancer-health-disparities-fact-sheet#q4. Accessed May 5, 2017.
2. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Jemal A, Pinheiro PS, et al. ACS report. Cancer remains leading cause of death in U.S. Hispanics. Oncol Times. 2015;37(20):30–1.
3. Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65:457–80.
4. Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H. Disparities between Blacks and Whites in tobacco and lung cancer treatment. Oncologist. 2011;16(10):1428–34.
5. de Dios MA, Anderson BJ, Stanton C, Audet DA, Stein M. Project impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers. J Subst Abuse Treat. 2012;43(3):322–30.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献